By Lana Pine | Published on December 17, 2025 4 min read A large real-world study published in Neurology found that people with Type 2 diabetes taking glucagon-like peptide-1 (GLP-1) receptor agonists had a lower risk of developing epilepsy than those taking dipeptidyl peptidase-4 (DPP-4) inhibitors
Research shows that TENS, PEMF, and H-Wave devices can reduce neuropathic pain
Unlike steroids, PRP promotes healing and has fewer long-term side effects, offering a more sustainable solution to chronic sciatica
Ayrca, ye, oluturduu yelik hesab ismi ve ifresini gizli tutacan, nc kiilerle paylamayacan ve paylat takdirde doabilecek zararlardan sorumlu olacan kabul ve taahht eder
CMS estimated that about 55 percent of obese Medicare beneficiaries would meet the behavioral engagement threshold
These findings suggest that Berberine may offer measurable benefits for weight loss when used consistently